Ondansetron Hydrochloride Ondansetron 4 MG Oral Tablet
1 INDICATIONS AND USAGE Ondansetron tablets are indicated for the prevention of nausea and vomiting associated with: highly emetogenic cancer chemotherapy, including cisplatin greater than or equal to 50 mg/m 2 initial and repeat courses of moderately emetogenic cancer chemotherapy radiotherapy in patients receiving either total body irradiation, single high-dose fraction to the abdomen, or daily fractions to the abdomen Ondansetron tablets are also indicated for the prevention of postoperative nausea and/or vomiting. Ondansetron tablets are a 5-HT 3 receptor antagonist indicated for the prevention of: nausea and vomiting associated with highly emetogenic cancer chemotherapy, including cisplatin greater than or equal to 50 mg/m 2 . (1) nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy. (1) nausea and vomiting associated with radiotherapy in patients receiving either total body irradiation, single high-dose fraction to the abdomen, or daily fractions to the abdomen. (1) postoperative nausea and/or vomiting. (1)
aurobindo pharma limited
OVAL WHITE F 91
Related Pills
Ondansetron Hydrochloride Ondansetron 4 MG Oral Tablet
Aurobindo Pharma Limited
Ondansetron Hydrochloride Ondansetron 4 MG Oral Tablet
Aurobindo Pharma Limited
ondansetron 4 MG Oral Tablet
American Health Packaging
ondansetron 4 MG Oral Tablet
Cardinal Health
ondansetron 4 MG Oral Tablet
Cardinal Health
ondansetron 4 MG Oral Tablet
Cardinal Health
ondansetron 4 MG Oral Tablet
Cardinal Health
ondansetron 4 MG Oral Tablet
American Health Packaging
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING Ondansetron Tablets USP, 4 mg are white to off-white, oval shaped, film-coated tablets debossed with ‘F’ on one side and ‘91’ on the other side. Bottles of 30 NDC 65862-187-30 Bottles of 500 NDC 65862-187-05 Bottles of 1,000 NDC 65862-187-99 1 x 3 Unit-dose Tablets NDC 65862-187-03 10 x 10 Unit-dose Tablets NDC 65862-187-10 Ondansetron Tablets USP, 8 mg are yellow colored, oval shaped, film-coated tablets debossed with ‘F’ on one side and ‘92’ on the other side. Bottles of 30 NDC 65862-188-30 Bottles of 500 NDC 65862-188-05 Bottles of 1,000 NDC 65862-188-99 1 x 3 Unit-dose Tablets NDC 65862-188-03 10 x 10 Unit-dose Tablets NDC 65862-188-10 Ondansetron Tablets USP, 24 mg are pink colored, oval shaped, film-coated tablets debossed with ‘C’ on one side and ‘71’ on the other side. Unit-dose Packs of 1 Tablet NDC 65862-189-11 Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Protect from light.
More pills like OVAL F 91